Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.

被引：0
|
作者：
Saito, Ryota
Inoue, Akira
Sugawara, Shunichi
Oizumi, Satoshi
Maemondo, Makoto
Okudera, Koichi
Suzuki, Toshiro
Usui, Kazuhiro
Harada, Masao
Morikawa, Naoto
Hasegawa, YUkihiro
Ishimoto, Osamu
Sakakibara, Tomohiro
Asahina, Hajime
Nukiwa, Toshihiro
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
[4] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan
[5] Hirosaki Chuo Hosp, Hirosaki, Aomori, Japan
[6] Iwate Isawa Hosp, Oushu, Japan
[7] Kanto Med Ctr NTT EC, Tokyo, Japan
[8] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[9] Tohoku Kosei Nenkin Hosp, Sendai, Miyagi, Japan
[10] Aomori Prefectural Cent Hosp, Aomori, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7086
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of combination therapy with liposomal doxorubicin and carboplatin (CBDCA) in patients (pts) with previously untreated small cell lung cancer (SCLC).
    Vorobiof, DA
    Rapoport, BL
    Slabber, CF
    Alberts, AS
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 690S - 690S
  • [32] Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
    Kato, T.
    Nokihara, H.
    Ohe, Y.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Kubota, K.
    Nishiwaki, Y.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [33] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] PHASE I STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED LUNG CANCER: CENTRAL JAPAN LUNG STUDY GROUP (CJLSG) 0601 TRIAL
    Kitagawa, C.
    Saka, H.
    Adachi, T.
    Kajikawa, S.
    Mori, K.
    Kogure, Y.
    Oki, M.
    Shimokata, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 116 - 116
  • [35] Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Kodama, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (01) : 86 - 90
  • [36] Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
    Kakolyris, S
    Mavroudis, D
    Tsavaris, N
    Souglakos, J
    Tsiafaki, P
    Kalbakis, K
    Agelaki, S
    Androulakis, N
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 193 - 197
  • [37] Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 86 - 90
  • [38] Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer
    Yamamoto, N
    Tsurutani, J
    Yoshimura, N
    Asai, G
    Moriyama, A
    Nakagawa, K
    Kudoh, S
    Takada, M
    Minato, Y
    Fukuoka, M
    ANTICANCER RESEARCH, 2006, 26 (1B) : 777 - 781
  • [39] A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer
    Han, Ji-Youn
    Kim, Hyae Young
    Lim, Kun Young
    Han, Jong Hee
    Lee, You Jin
    Kwak, Mi Hyang
    Kim, Hak Jin
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    LUNG CANCER, 2013, 79 (02) : 137 - 142
  • [40] Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Pietanza, Maria Catherine
    Pereira, Leanne
    Dunne, Meghan
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Holodny, Andrei
    Kris, Mark G.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S819 - S820
12345